Skip to main content

Table 3 Clinical characteristics of four ROP patients carrying FZD4 mutations

From: Ocular phenotype and genetical analysis in patients with retinopathy of prematurity

Patient ID

Gender

Gestational age

Birth weight

Stage of ROP

Treatment

P09

Male

28 w

1250 g

3 (OU)

IVR (OU) at 10 w after birth

P11

Male

33 w

2400 g

4A (OU)

IVR (OU) at 7 w after birth

P18

Male

30 w

1150 g

3 (OU)

IVR (OU) at 9 w after birth

P30

Female

32 w

1950 g

0 (OU)

  1. w weeks, g grams, IVR intravitreal ranibizumab